Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

KYTHERA Biopharmaceuticals Inc (NASDAQ:KYTH)

Delayed Data
As of Aug 27
 -0.03 / -0.04%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for KYTHERA Biopharmaceuticals Inc have a median target of 69.50, with a high estimate of 75.00 and a low estimate of 64.00. The median estimate represents a -6.95% decrease from the last price of 74.69.

Analyst Recommendations

The current consensus among 2 polled investment analysts is to Buy stock in KYTHERA Biopharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 06

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 4.44%
Growthannually -25.95%


Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.